Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
90,781,827
-
Share change
-
+4,516,738
-
Total reported value
-
$6,146,494,198
-
Put/Call ratio
-
226%
-
Price per share
-
$67.72
-
Number of holders
-
361
-
Value change
-
+$308,483,097
-
Number of buys
-
171
-
Number of sells
-
160
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q3 2019
As of 30 Sep 2019,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
361 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,781,827 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, BAILLIE GIFFORD & CO, BANK OF AMERICA CORP /DE/, WELLINGTON MANAGEMENT GROUP LLP, WADDELL & REED FINANCIAL INC, ALLIANCEBERNSTEIN L.P., JANUS HENDERSON GROUP PLC, and MACQUARIE GROUP LTD.
This page lists
363
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.